Manuel Comabella
Overview
Explore the profile of Manuel Comabella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
229
Citations
6150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dominguez-Mozo M, Lopez-Mecandez D, Villar L, Costa-Frossard L, Villarrubia N, Aladro Y, et al.
Ann Clin Transl Neurol
. 2025 Mar;
PMID: 40033709
Objective: An alteration in the composition of the intestinal microbiota has been observed in patients with multiple sclerosis (pwMS) with respect to healthy controls (HC). Microorganism-derived metabolites such as short-chain...
2.
Marrodan M, Sao Aviles A, Rio J, Cobo-Calvo A, Fernandez V, Pappolla A, et al.
Mult Scler
. 2025 Feb;
:13524585251316471.
PMID: 39925147
Background: Predicting treatment response and disease progression in multiple sclerosis (MS) is challenging. Treatment Response Scoring Systems (TRSS) are potentially useful, but their utility in patients receiving high-efficacy therapies and...
3.
Vilaseca A, Tintore M, Carbonell-Mirabent P, Rodriguez-Barranco M, Arevalo M, Arino H, et al.
Mult Scler
. 2025 Feb;
:13524585251314749.
PMID: 39907218
Background: It is essential to exclude alternative diagnoses to diagnose multiple sclerosis (MS). However, detailed descriptions of alternative diagnoses in patients with suspected MS presenting with clinically isolated syndrome (CIS)...
4.
Cobo-Calvo A, Carbonell-Mirabent P, Tur C, Otero-Romero S, Carvajal R, Arrambide G, et al.
Neurology
. 2025 Feb;
104(4):e210305.
PMID: 39903901
Background And Objectives: Emerging concepts in the early detection of multiple sclerosis (MS) progression reveal that disability accumulation can start early in the disease course. Aging in MS is increasingly...
5.
Comabella M, Pappolla A, Monreal E, Fissolo N, Sao-Aviles A, Arrambide G, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Jan;
12(2):e200370.
PMID: 39879564
Background And Objectives: Invasive procedures may delay the diagnostic process in multiple sclerosis (MS). We investigated the added value of serum neurofilament light chain (sNfL), glial fibrillary acidic protein (sGFAP),...
6.
Behrens M, Comabella M, Lunemann J
Front Immunol
. 2025 Jan;
15():1509927.
PMID: 39776919
Genetic and environmental factors jointly determine the susceptibility to develop multiple sclerosis (MS). Improvements in the design of epidemiological studies have helped to identify consistent environmental risk associations such as...
7.
Comabella M, Hegen H, Villar L, Rejdak K, Sao-Aviles A, Behrens M, et al.
J Neurol
. 2024 Dec;
272(1):26.
PMID: 39666032
Background And Objectives: The impact of viral infections on disease susceptibility and progression has predominantly been studied in patients with relapse-onset MS (RMS). Here, we determined immune responses to ubiquitous...
8.
Villacieros-Alvarez J, Lunemann J, Sepulveda M, Valls-Carbo A, Dinoto A, Fernandez V, et al.
Neurol Neuroimmunol Neuroinflamm
. 2024 Dec;
12(1):e200340.
PMID: 39661937
Background And Objectives: The role of the complement system in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is not completely understood, and studies exploring its potential utility for diagnosis and prognosis...
9.
Pinteac R, Soriano J, Matute-Blanch C, Lizcano J, Duarri A, Malhotra S, et al.
Clin Transl Med
. 2024 Dec;
14(12):e70125.
PMID: 39658520
No abstract available.
10.
Chuquisana O, Spatola M, Dinoto A, Sepulveda M, Mariotto S, Tintore M, et al.
Brain
. 2024 Nov;
148(2):e4-e7.
PMID: 39530260
No abstract available.